Interestingly, avexitide, a GLP-1 antagonist, reduced postprandial insulin secretion and subsequent hypoglycemia in PBH, but this is not yet approved by the USA Food and Drug Administration [10]. The gene discussed is GLP1R; the disease is Hypoglycemia.